Practice and Progress in Cardiac Pacing and Electrophysiology

Front Matter....Pages i-xx
Endpoints and trials: a matter of life and death. Classification of death in patients under antiarrhythmic treatment....Pages 1-5
The role of transient ischaemia in the pathophysiology of ventricular arrhythmias in patients with coronary artery disease....Pages 7-12
Sudden death and tachyarrhythmias in athletes....Pages 13-21
The evaluation of antiarrhythmics....Pages 23-28
Atrial fibrillation: maintaining the sinus rhythm....Pages 29-35
Arrhythmogenic right ventricular dysplasia....Pages 37-46
Signal averaged electrocardiogram. Current applications and limitations....Pages 47-61
Can analysis of heart rate variability predict arrhythmias and antiarrhythmic effects?....Pages 63-69
QT dispersion....Pages 71-75
Use of baroreceptor reflex sensitivity in the prediction of risk after myocardial infarction....Pages 77-91
Ambulatory monitoring of T-wave alternans for detection of cardiac electrical instability: scientific rationale and technical considerations....Pages 93-102
The state of electrical cardiac stimulation — 1995....Pages 103-111
Long-term rate adaptive atrial (AAIR) pacing: is it feasible?....Pages 113-117
Single lead atrial synchronised ventricular (VDD) pacing....Pages 119-125
Benefits of sensor driven dual chamber pacing....Pages 127-136
Cardiopulmonary evaluation of patients with rate responsive pacemakers....Pages 137-141
Programming the upper rate behaviour and the atrial escape interval in paced patients with unstable atrium....Pages 143-149
Automatic mode switching in DDDR pacemakers....Pages 151-160
Pacing to prevent arrhythmias: bradycardia/tachycardia syndrome....Pages 161-165
Managing paroxysmal atrial tachycardias in patients with pacemakers....Pages 167-173
Pacing to prevent atrial fibrillation....Pages 175-187
The paradigm shift: pacing to prevent arrhythmias. Ventricular tachycardia....Pages 189-197
How may dilated cardiomyopathy benefit from cardiac pacing?....Pages 199-208
Various methods of monitoring the autonomic nervous system using the pacing lead as a sensor. Clinical results and prospectives....Pages 209-238
Rationale for the management of pacemaker and defibrillator complications....Pages 239-248
Radiofrequency ablation of atrial flutter....Pages 249-258
The spectrum of “Mahaim-like” accessory connections and their associated ablation techniques....Pages 259-267
New approaches to ablation of left-sided and posteroseptal accessory pathways....Pages 269-276
Advances in transcatheter endocardial mapping and radiofrequency ablation of ventricular arrhythmias....Pages 277-287
Catheter ablation of ventricular tachycardia in patients with coronary heart disease....Pages 289-307
Internal atrial defibrillation and implantable atrial defibrillators....Pages 309-316
The cardiologist’s dilemma: Drugs or ICDs in patients with severe ventricular dysfunction....Pages 317-327
Can pump failure in ICD patients with low ejection fraction be avoided by adding new pacing modes to current ICD’s?....Pages 329-335
Long-term outcome with transvenous (-subcutaneous) defibrillation leads....Pages 337-346
Insights into ventricular tachycardia onset mechanism from analysis of stored ICD electrograms....Pages 347-352
Managing the problem of atrial tachyarrhythmias in patients with ICD’s....Pages 353-360
Technological advances in implantable cardioverter defibrillator leads and waveforms: paving the way for smaller ICDs....Pages 361-370
Driving restrictions after cardioverter/defibrillator implantation....Pages 371-379
Arrhythmias, implantable devices and driving “The United Kingdom Advisory Panel Experience”....Pages 381-386
Back Matter....Pages 387-391